BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
200 hedge funds and large institutions have $3.01B invested in bluebird bio in 2016 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 64 increasing their positions, 60 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10% less call options, than puts
Call options by funds: $51.9M | Put options by funds: $58M
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
200
Holding in Top 10
1
Calls
$51.9M
Puts
$58M
Top Buyers
| 1 | +$62.5M | |
| 2 | +$44.4M | |
| 3 | +$29.5M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$21.9M |
| 5 |
PC
Passport Capital
San Francisco,
California
|
+$19.6M |
Top Sellers
| 1 | -$38.2M | |
| 2 | -$36M | |
| 3 | -$35.5M | |
| 4 |
TAM
Tiverton Asset Management
Wilimington,
Delaware
|
-$31.1M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$21.6M |